The best approach for protecting everyone’s health will require us to provide different vaccines to different people according to need and availability.
Despite the latest tweaks to border testing rules, the risk of imported infection remains very high. NZ's wider response needs upgrading —including reducing the large numbers of infected returnees.
With reports emerging of vaccine wastage across the world, medical supply chain experts explain why that's to be expected.
A market place in Ghana’s capital Accra. Developing countries like Ghana risk being left behind in the race to secure COVID-19 vaccines.
Christian Thompson/Anadolu Agency via Getty Images
A waiver on some intellectual property rules at the WTO for COVID-19 vaccines would ensure more equitable access, but wouldn't solve all the problems facing developing countries.
Seniors in Fort Myers, Fla. wait for their COVID-19 vaccinations. At this site, 800 doses of vaccine were available.
Octavio Jones via Getty Images
The shipment of goods to suppliers has become technologically sophisticated. Delays in getting out the COVID-19 vaccine to people show that the breakdowns come down to something more basic.
COVID-19 vaccines could substantially reduce hospital admissions, but will be slower at freeing up space in intensive care.
A medical professor explains the reasoning behind the delay in the UK and what impact this might have on the vaccine's effectiveness.
Australia's expedited plan to start dishing out COVID jabs in mid-late February will call for NASA-like logistical organisation. And ideally, no more clusters of infections to distract frontline workers.
Zorro Stock Images/Shutterstock
Our research can help understand the role schools play in transmission.
Before the U.S. can return to some form of normal, a lot of people need to be vaccinated.
AP Photo/Paul Sancya, Pool
Researchers say around 70% of the US needs to get the coronavirus vaccine to stop the pandemic. But questions around the vaccines and regional differences add some uncertainty to that estimate.
Are immunity passports an idea that we should be seriously considering?
THE CANADIAN PRESS/John Woods
Even though the idea has been rejected earlier in the COVID-19 pandemic, we need to rethink immunity passports. Here's why.
Latrice Davis, a nurse at Roseland Community Hospital in Chicago, receives the COVID-19 vaccine on Dec. 18, 2020.
Scott Olson via Getty Images
Black people are skeptical about the new vaccines for many reasons. If public health leaders told the full story, maybe there'd be a higher chance that Black people would want to take the vaccine.
A patient care director in New York receives the coronavirus vaccine.
Eduardo Munoz/Pool via AP
The federal agency in charge of enforcing discrimination laws in the workplace said 'yes,' but there are some important exceptions and limitations.
Pharmacist Jessica Sahni prepares a Pfizer COVID-19 vaccine in New York City.
Bryan R. Smith/AFP via Getty Images
Now that two COVID vaccines have been authorized by the FDA, questions arise. Today, a physician from Indiana University School of Medicine answers five reader questions.
Sandra Lindsay, left, a nurse at Long Island Jewish Medical Center, is inoculated with the COVID-19 vaccine by Dr. Michelle Chester.
Mark Lennihan/Pool via Getty Images
A serious allergic reaction was reported in a health care worker in Alaska after she received the COVID-19 vaccine. Does this mean that people with allergies need to be concerned? An expert answers.
A dose of the Pfizer vaccine being prepared to be given to a health worker in California, USA.
Experts from across The Conversation assess the work that's helped us reach vaccine roll-out, how this could play out, and the risk of vaccine hesitancy.
We still don't know if current vaccines prevent people from transmitting the virus to others. Here's why that matters in 2021.
Sandra Lindsay, a nurse at Long Island Jewish Medical Center, is given the COVID-19 vaccine – she is one of the first in the US to receive it.
Here's what we still need to find out before we can know when we'll be able to return to our pre-coronavirus ways.
Francesca Passer, a registered pharmacist technician, carefully fills a syringe with the Pfizer-BioNTech COVID-19 mRNA vaccine at a vaccine clinic during the COVID-19 pandemic in Toronto on Dec. 15, 2020.
THE CANADIAN PRESS/Nathan Denette
Employers could require their workers to get vaccinated against COVID-19 via both workplace policies and existing laws. Neither option, however, is simple or straightforward.
There have been a few accounts of patients who have tested positive, then negative, then positive again for COVID-19.
So, if you have ever tested positive, there is a chance you could contract the virus again. And you could infect other people. You should still take the necessary precautions.